NPCE

Neuropace Inc

NPCE, USA

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

https://www.neuropace.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NPCE
stock
NPCE

Wells Fargo Upgrades NeuroPace(NPCE.US) to Buy Rating, Raises Target Price to $19 富途牛牛

Read more →
NPCE
stock
NPCE

NeuroPace (NASDAQ:NPCE) Price Target Raised to $20.00 at JPMorgan Chase & Co. Defense World

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$17.5

Analyst Picks

Strong Buy

6

Buy

2

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

28.97

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-18.88 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-3.26 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-7.22 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

4.79

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 84.43% of the total shares of Neuropace Inc

1.

Orbimed Advisors, LLC

(7.9023%)

since

2025/06/30

2.

Polar Capital Healthcare Opports Inc

(7.8281%)

since

2025/07/31

3.

Morgan Stanley - Brokerage Accounts

(7.8143%)

since

2025/06/30

4.

BlackRock Inc

(7.0105%)

since

2025/06/30

5.

Soleus Capital Management, L.P.

(6.9917%)

since

2025/06/30

6.

First Light Asset Management, LLC

(4.1728%)

since

2025/06/30

7.

Vanguard Group Inc

(4.1391%)

since

2025/06/30

8.

Armistice Capital, LLC

(3.4833%)

since

2025/06/30

9.

Driehaus Capital Management LLC

(3.039%)

since

2025/06/30

10.

Deutsche Bank AG

(2.8075%)

since

2025/06/30

11.

Kent Lake PR LLC

(2.7961%)

since

2025/06/30

12.

Vanguard Total Stock Mkt Idx Inv

(2.5093%)

since

2025/07/31

13.

Xtrackers MSCI World Swap ETF 1C

(2.2424%)

since

2025/07/31

14.

FMR Inc

(1.8906%)

since

2025/06/30

15.

iShares Russell 2000 ETF

(1.7964%)

since

2025/08/31

16.

Polar Capital Glb Healthcare Ord

(1.5363%)

since

2025/07/31

17.

Deerfield Management Co

(1.5114%)

since

2025/06/30

18.

Geode Capital Management, LLC

(1.4666%)

since

2025/06/30

19.

Fidelity Small Cap Growth

(1.2426%)

since

2025/06/30

20.

Lord, Abbett & Co LLC

(1.2114%)

since

2025/06/30

21.

State Street Corp

(1.1146%)

since

2025/06/30

22.

Silvercrest Asset Management Group LLC

(0.9031%)

since

2025/06/30

23.

Nantahala Capital Management, LLC

(0.892%)

since

2025/06/30

24.

BlackRock Advantage Small Cap Core Instl

(0.7471%)

since

2025/07/31

25.

Divisadero Street Capital Management, LP

(0.7319%)

since

2025/06/30

26.

Fidelity Small Cap Index

(0.727%)

since

2025/06/30

27.

Northern Trust Corp

(0.7013%)

since

2025/06/30

28.

Heptagon Driehaus US Micro Cap Eq C$ Acc

(0.6713%)

since

2025/07/31

29.

iShares Russell 2000 Growth ETF

(0.6316%)

since

2025/08/31

30.

Fidelity Small Cap Growth K6

(0.6221%)

since

2025/06/30

31.

Vanguard Institutional Extnd Mkt Idx Tr

(0.5327%)

since

2025/07/31

32.

Xtrackers S&P 500 Swap ETF 1C

(0.5164%)

since

2025/07/31

33.

Palumbo Wealth Management LLC

(0.5135%)

since

2025/06/30

34.

Vanguard Russell 2000 ETF

(0.3456%)

since

2025/07/31

35.

Lord Abbett Micro Cap Growth I

(0.291%)

since

2025/06/30

36.

Driehaus Micro Cap Growth USD

(0.2871%)

since

2025/07/31

37.

Silvercrest U.S. Small Cap Growth

(0.2821%)

since

2025/06/30

38.

Fidelity Extended Market Index

(0.2717%)

since

2025/07/31

39.

State St Russell Sm Cap® Indx SL Cl I

(0.2563%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.1919

Latest Release

Date

2025-09-30

EPS Actual

-0.11

EPS Estimate

-0.1959

EPS Difference

0.0859

Surprise Percent

43.8489%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(1.5)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1)
Economic Moat
No Clear Moat(2.8)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(2)
Momentum
No Momentum(2)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(1)
Value
Overpriced(1.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.